Hong Kong Pharmaceutical Consulting

Hong Kong’s pharmaceutical market is worth about $1 billion. Despite its small population of about 8 million people, Hong Kong is a relatively affluent country with high healthcare standards. PBM has carried out several pharmaceutical consulting projects in Hong Kong. We have assisted pharmaceutical clients in marketing and distribution of drugs, sourcing of APIs, partner searches and setting up business ventures in Hong Kong’s drug market.

There are currently close to 40 registered pharmaceutical manufacturers in Hong Kong. Most of these local drug manufacturers produce generic drugs. More advanced drugs are generally imported from Europe and the US. There is a high usage of patented drugs in Hong Kong to treat chronic illnesses. This is due to higher incidence of lifestyle-related diseases, as well as a gradually aging population in Hong Kong. Cancer, respiratory and cardiovascular diseases are currently the leading causes of death in Hong Kong. International companies who are interested in exporting their drugs to Hong Kong can turn to PBM’s pharmaceutical consultants for professional guidance.

Pharmaceutical companies need to know about Hong Kong’s healthcare regulations to succeed. The Hong Kong Department of Health (DOH) is responsible for health legislation and policy. Under the DOH, the Pharmaceutical Service sector is responsible for drug registration and drug import/export control in Hong Kong. After a bout of unfortunate incidents in Hong Kong that resulted in patient deaths in 2009, a review to improve drug controls was conducted by the Ministry of Health. This review was published in 2010, with some recommendations for stricter manufacturing, distribution and other commercial practices in Hong Kong’s pharmaceutical industry.

PBM’s Hong Kong pharmaceutical consultants possess deep insight and knowledge of the country’s healthcare dynamics and regulations. Equipped with years of experience in the pharmaceutical market, each Hong Kong pharmaceutical consultant offers value-added consulting services to international drug companies.

Please contact us for inquiries about PBM’s Hong Kong pharmaceutical consultant services, or view PBM’s publications for more articles on Hong Kong’s drug market.